Multiparametric mri of the prostate as a tool for prostate cancer detection, localization, and risk assessment

Marc A. Bjurlin, Neil Mendhiratta, Samir S. Taneja

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Advances in multiparametric magnetic resonance imaging (mpMRI) hold promise for the improved detection and characterization of prostate cancer. MpMRI combines diffusion-weighted imaging, dynamic contrast-enhanced sequences, or spectroscopy with conventional T2-weighted sequences. With a combination of anatomic and functional imaging sequences to identify suspicious regions in the prostate, pre-biopsy mpMRI has the potential to improve prostate cancer detection and risk stratification through MRI-targeted biopsy. In this chapter we review the role of mpMRI in prostate cancer detection, the outcomes of MRI-targeted biopsy, and the critical concepts currently under evaluation in validation of an MRI-based prostate cancer risk stratification strategy.

Original languageEnglish (US)
Title of host publicationThe Prostate Cancer Dilemma
Subtitle of host publicationSelecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy
PublisherSpringer International Publishing
Pages107-126
Number of pages20
ISBN (Electronic)9783319214856
ISBN (Print)9783319214849
DOIs
StatePublished - Jan 1 2016

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Multiparametric mri of the prostate as a tool for prostate cancer detection, localization, and risk assessment'. Together they form a unique fingerprint.

Cite this